Publication Name	World Journal of Hepatology
Manuscript ID	94160
Country	Iraq

Received	2024-03-12 14:12
Peer-Review Started	2024-03-12 14:12
To Make the First Decision
Return for Revision	2024-08-07 13:18
Revised	2024-08-12 07:47
Second Decision	2024-08-26 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-08-26 08:24
Articles in Press	2024-08-26 08:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-08-29 07:32
Publish the Manuscript Online	2024-09-23 10:30

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Concomitant determination of hematological indices supported the application of the albumin-bilirubin score in non-malignant liver diseases
Manuscript Source	Invited Manuscript
All Author List	Marwan S M Al-Nimer
ORCID	Author(s) ORCID Number Marwan S M Al-Nimer http://orcid.org/0000-0002-5336-3353
Funding Agency and Grant Number
Corresponding Author	Marwan S M Al-Nimer, MBChB, MD, PhD, Professor Emerita, Department of Pharmacology, College of Medicine, University of Diyala, University Street, Baqubah 32001, Iraq. marwanalnimer@yahoo.com
Key Words	Albumin-bilirubin score; Hepatocellular carcinoma; Non-malignant diseases; Platelet-‎lymphocyte ratio; Platelet-hemoglobin ratio
Core Tip	Albumin-bilirubin (ALBI) score is a prognostic biomarker in hepatocellular carcinoma and non-malignant liver diseases, as a higher level in the pretreatment state is associated with poor prognosis. Hematological ratios, notably the platelet-lymphocyte ratio (PLR) and platelet-hemoglobin ratio (PHR) are also useful prognostic biomarkers in hepatic pathological conditions. Concurrent measurement of PLR and ALBI score, or ALBI score and PHR, supports the prediction value of the ALBI score and makes sense to establish a cutoff value for non-malignant conditions.
Publish Date	2024-09-23 10:30
Citation	<p>Al-Nimer MSM. Concomitant determination of hematological indices supported the application of the albumin-bilirubin score in non-malignant liver diseases. <i>World J Hepatol</i> 2024; 16(9): 1308-1311</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i9/1308.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i9.1308

Full Article (PDF)	WJH-16-1308-with-cover.pdf
Manuscript File	94160_Auto_Edited_032019.docx
Answering Reviewers	94160-answering-reviewers.pdf
Audio Core Tip	94160-audio.m4a
Conflict-of-Interest Disclosure Form	94160-conflict-of-interest-statement.pdf
Copyright License Agreement	94160-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	94160-non-native-speakers.pdf
Peer-review Report	94160-peer-reviews.pdf
Scientific Misconduct Check	94160-scientific-misconduct-check.png
Scientific Editor Work List	94160-scientific-editor-work-list.pdf
CrossCheck Report	94160-crosscheck-report.png
CrossCheck Report	94160-crosscheck-report.pdf